                         SEQUENCE LISTING

<110>  Webb, Thomas R.
       Shi, Yihui
       Park, Jaehyeon
       Lagisetti, Chandraiah
       Zhou, Wei
       Sambucetti, Lidia C.
 
<120>  DUAL CLK/CDK1 INHIBITORS FOR CANCER TREATMENT

<130>  37794.0001P1

<150>  US 62/402,876
<151>  2016-09-30

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  1

Glu Arg Met Arg Pro Arg Lys Arg Gln Gly Ser Val Arg Arg Arg Val 
1               5                   10                  15      


<210>  2
<211>  27
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  2

Tyr Arg Arg Ala Ala Val Pro Pro Ser Pro Ser Leu Ser Arg His Ser 
1               5                   10                  15      


Ser Pro His Gln Ser Pro Glu Asp Glu Glu Glu 
            20                  25          


<210>  3
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  3

Glu Arg Met Arg Pro Arg Lys Arg Gln Gly Ser Val Arg Arg Arg Val 
1               5                   10                  15      


<210>  4
<211>  27
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  4

Tyr Arg Arg Ala Ala Val Pro Pro Ser Pro Ser Leu Ser Arg His Ser 
1               5                   10                  15      


Ser Pro His Gln Ser Pro Glu Asp Glu Glu Glu 
            20                  25          


<210>  5
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  5

Glu Ala Ile Tyr Ala Ala Pro Phe Ala Lys Lys Lys 
1               5                   10          


<210>  6
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  6

Leu Arg Arg Ala Ser Leu Gly 
1               5           


<210>  7
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  7

Ala Lys Arg Arg Arg Leu Ser Ser Leu Arg Ala 
1               5                   10      


<210>  8
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  8

Glu Ala Ile Tyr Ala Ala Pro Phe Ala Lys Lys Lys 
1               5                   10          


<210>  9
<211>  14
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  9

Lys Lys Lys Ser Pro Gly Glu Tyr Val Asn Ile Glu Phe Gly 
1               5                   10                  


<210>  10
<211>  23
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  10

Lys Lys Lys Lys Glu Arg Leu Leu Asp Asp Arg His Asp Ser Gly Leu 
1               5                   10                  15      


Asp Ser Met Lys Asp Glu Glu 
            20              


<210>  11
<211>  39
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  11

Lys Thr Phe Cys Gly Thr Pro Glu Tyr Leu Ala Pro Glu Val Arg Arg 
1               5                   10                  15      


Glu Pro Arg Ile Leu Ser Glu Glu Glu Gln Glu Met Phe Arg Asp Phe 
            20                  25                  30          


Asp Tyr Ile Ala Asp Trp Cys 
        35                  


<210>  12
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  12

Gly Gly Glu Glu Glu Glu Tyr Phe Glu Leu Val Lys Lys Lys Lys 
1               5                   10                  15  


<210>  13
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic construct

<400>  13

Gly Gly Glu Glu Glu Glu Tyr Phe Glu Leu Val Lys Lys Lys Lys 
1               5                   10                  15  


